Progressive histological damage in liver allografts following pediatric liver transplantation

Hepatology

Volumn 43, Issue 5, 2006, Pages 1109-1117

  Evans, Helen M ^a   Kelly, Deirdre A ^a   McKiernan, Patrick J ^a   Hübscher, Stefan ^b  

^a BIRMINGHAM CHILDREN S HOSPITAL   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CORTICOSTEROID; CYCLOSPORIN A;

ALLOGRAFT; ARTICLE; AUTOIMMUNE HEPATITIS; CHILD; CHILD CARE; CHRONIC HEPATITIS; CONTROLLED STUDY; FEMALE; GRAFT DYSFUNCTION; GRAFT REJECTION; GRAFT SURVIVAL; HISTOLOGY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; TREATMENT INDICATION; TREATMENT OUTCOME;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; DISEASE PROGRESSION; FEMALE; FIBROSIS; HEPATITIS; HUMANS; INFANT; LIVER DISEASES; LIVER TRANSPLANTATION; MALE; TIME FACTORS;

EID: 33646558290     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.21152     Document Type: Article

References (42)

1. Kelly DA. Current results and evolving indications for liver transplantation in children. J Pediatr Gastroenterol Nutr 1998;27:214-221.
2. Wallot MA, Mathot M, Janssen M, Holter T, Paul K, Buts JP, et al. Long-term survival and late graft loss in pediatric liver transplant recipients: a 15-year single-center experience. Liver Transpl 2002;8:615-622.
3. Pappo O, Ramos H, Starzl TE, Fung JJ, Demetris AJ. Structural integrity and identification of causes of liver allograft dysfunction occurring more than 5 years after transplantation. Am J Surg Pathol 1995;19:192-206.
4. Slapak GI, Saxena R, Portmann B, Gane E, Devlin J, Calne R, et al. Graft and systemic disease in long-term survivors of liver transplantation. HEPATOLOGY 1997;25:195-202.
5. Sebagh M, Rifai K, Feray C, Yilmaz F, Falissard B, Roche B, et al. All liver recipients benefit from the protocol 10-year liver biopsies. HEPATOLOGY 2003;37:1293-1301.
6. Pessoa MG, Terrault NA, Ferrell LD, Detmer J, Kolberg J, Collins ML, et al. Hepatitis after liver transplantation: the role of the known and unknown viruses. Liver Transpl Surg 1998;4:461-468.
7. Heneghan MA, Portmann BC, Norris SM, Williams R, Muiesan P, Rela M, et al. Graft dysfunction mimicking autoimmune hepatitis following liver transplantation in adults. HEPATOLOGY 2001;34:464-470.
8. Kerkar N, Hadzic N, Davies ET, Portmann B, Donaldson PT, Rela M, et al. De-novo autoimmune hepatitis after liver transplantation. Lancet 1998;351:409-413.
9. Andries S, Casamayou L, Sempoux C, Burlet M, Reding R, Bernard OJ, et al. Posttransplant immune hepatitis in pediatric liver transplant recipients: incidence and maintenance therapy with azathioprine. Transplantation 2001;72:267-272.
10. Gupta P, Hart J, Millis JM, Cronin D, Brady L. De novo hepatitis with autoimmune antibodies and atypical histology: a rare cause of late graft dysfunction after pediatric liver transplantation. Transplantation 2001;71:664-668.
11. Hernandez HM, Kovarik P, Whitington PF, Alonso EM. Autoimmune hepatitis as a late complication of liver transplantation. J Pediatr Gastroenterol Nutr 2001;32:131-136.
12. Jones DE, James OF, Portmann B, Burt AD, Williams R, Hudson M. Development of autoimmune hepatitis following liver transplantation for primary biliary cirrhosis. HEPATOLOGY 1999;30:53-57.
13. Vergani D, Mieli-Vergani G. Autoimmunity after liver transplantation. HEPATOLOGY 2002;36:271-276.
14. Tan CK, Sian Ho JM. Concurrent de novo autoimmune hepatitis and recurrence of primary biliary cirrhosis post-liver transplantation. Liver Transpl 2001;7:461-465.
15. Lucey MR. Serial liver biopsies: a gateway into understanding the long-term health of the liver allograft. J Hepatol 2001;34:762-763.
16. Rosenthal P, Emond JC, Heyman MB, Snyder J, Roberts J, Ascher N, et al. Pathological changes in yearly protocol liver biopsy specimens from healthy pediatric liver recipients. Liver Transpl Surg 1997;3:559-562.
17. Mohamed R, Hubscher SG, Mirza DF, Gunson BK, Mutimer DJ. Posttransplantation chronic hepatitis in fulminant hepatic failure. HEPATOLOGY 1997;25:1003-1007.
18. Hubscher SG, Elias E, Buckels JA, Mayer AD, McMaster P, Neuberger JM. Primary biliary cirrhosis. Histological evidence of disease recurrence after liver transplantation. J Hepatol 1993;18:173-184.
19. Peeters PM, Sieders E, vd HM, Bijleveld CM, de Jong KP, TenVergert EM, et al. Predictive factors for portal fibrosis in pediatric liver transplant recipients. Transplantation 2000;70:1581-1587.
20. Heneghan MA, Zolfino T, Muiesan P, Portmann BC, Rela M, Heaton ND, et al. An evaluation of long-term outcomes after liver transplantation for cryptogenic cirrhosis. Liver Transpl 2003;9:921-928.
21. Rifai K, Sebagh M, Karam V, Saliba F, Azoulay D, Adam R, et al. Donor age influences 10-year liver graft histology independently of hepatitis C virus infection. J Hepatol 2004;41:446-453.
22. Berenguer M, Rayon JM, Prieto M, Aguilera V, Nicolas D, Ortiz V, et al. Are posttransplantation protocol liver biopsies useful in the long term? Liver Transpl 2001;7:790-796.
23. Hubscher SG. Recurrent autoimmune hepatitis after liver transplantation: diagnostic criteria, risk factors, and outcome. Liver Transpl 2001;7:285-291.
24. Nakhleh RE, Krishna M, Keaveny AP, Dickson RC, Rosser B, Nguyen JH, et al. Review of 31 cases of morphologic hepatitis in liver transplant patients not related to disease recurrence. Transplant Proc 2005;37:1240-1242.
25. Davison SM, Skidmore SJ, Collingham KE, Irving WL, Hubscher SG, Kelly DA. Chronic hepatitis in children after liver transplantation: role of hepatitis C virus and hepatitis G virus infections. J Hepatol 1998;28:764-770.
26. Duclos-Vallee JC, Johanet C, Bach JF, Yamamoto AM. Autoantibodies associated with acute rejection after liver transplantation for type-2 autoimmune hepatitis. J Hepatol 2000;33:163-166.
27. Lohse AW, Obermayer-Straub P, Gerken G, Brunner S, Altes U, Dienes HP, et al. Development of cytochrome P450 2D6-specific LKM-autoantibodies following liver transplantation for Wilson's disease: possible association with a steroid-resistant transplant rejection episode. J Hepatol 1999;31:149-155.
28. D'Antiga L, Dhawan A, Portmann B, Francavilla R, Rela M, Heaton N, et al. Late cellular rejection in paediatric liver transplantation: aetiology and outcome. Transplantation 2002;73:80-84.
29. Miyagawa-Hayashino A, Haga H, Egawa H, Hayashino Y, Sakurai T, Minamiguchi S, et al. Outcome and risk factors of de novo autoimmune hepatitis in living-donor liver transplantation. Transplantation 2004;78:128-135.
30. Cakaloglu Y, Devlin J, O'Grady J, Sutherland S, Portmann BC, Heaton N et al. Importance of concomitant viral infection during late acute liver allograft rejection. Transplantation 1995;59:40-45.
31. Gao EK, Lo D, Cheney R, Kanagawa O, Sprent J. Abnormal differentiation of thymocytes in mice treated with cyclosporin A. Nature 1988;336:176-179.
32. Czaja AJ. Autoimmune hepatitis after liver transplantation and other lessons of self-tolerance. Liver Transpl 2002;8:505-513.
33. Neuberger J, Gunson B, Hubscher S, Nightingale P. Immunosuppression affects the rate of recurrent primary biliary cirrhosis after liver transplantation. Liver Transpl 2004;10:488-491.
34. Murphy MS, Harrison R, Davies P, Buckels JA, Mayer AD, Hubscher S, et al. Risk factors for liver rejection: evidence to suggest enhanced allograft tolerance in infancy. Arch Dis Child 1996;75:502-506.
35. Diem HV, Evrard V, Vinh HT, Sokal EM, Janssen M, Otte JB, et al. Pediatric liver transplantation for biliary atresia: results of primary grafts in 328 recipients. Transplantation 2003;75:1692-1697.
36. Fouquet V, Alves A, Branchereau S, Grabar S, Debray D, Jacquemin E, et al. Long-term outcome of pediatric liver transplantation for biliary atresia: a 10-year follow-up in a single center. Liver Transpl 2005;11:152-160.
37. Kim JS, Groteluschen R, Mueller T, Ganschow R, Bicak T, Wilms C, et al. Pediatric transplantation: the Hamburg experience. Transplantation 2005;79:1206-1209.
38. Avitzur Y, De Luca E, Cantos M, Jimenez-Rivera C, Jones N, Fecteau A, et al. Health status ten years after pediatric liver transplantation-looking beyond the graft. Transplantation 2004;78:566-573.
39. Jain A, Mazariegos G, Kashyap R, Green M, Gronsky C, Starzl TE, et al. Comparative long-term evaluation of tacrolimus and cyclosporine in pediatric liver transplantation. Transplantation 2000;70:617-625.
40. McDiarmid SV, Farmer DA, Goldstein LI, Martin P, Vargas J, Tipton JR, et al. A randomized prospective trial of steroid withdrawal after liver transplantation. Transplantation 1995;60:1443-1450.
41. Diem HV, Sokal EM, Janssen M, Otte JB, Reding R. Steroid withdrawal after pediatric liver transplantation: a long-term follow-up study in 109 recipients. Transplantation 2003;75:1664-1670.
42. Achilleos OA, Mirza DF, Talbot D, McKiernan P, Beath SV, Gunson BK, et al. Outcome of liver retransplantation in children. Liver Transpl Surg 1999;5:401-406.